Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

734
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
734
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

897
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
897
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.5K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

799
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
799

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Child Vaccination Status and Behavioral and Social Drivers of Vaccination Among Their Caregivers in the Philippines: Cross-Sectional Survey Study Comparison of Household, Mobile, and Online Modes.

Journal of medical Internet research·2026
Same author

Tuberculosis Cases and Deaths Averted by PEPFAR.

The New England journal of medicine·2026
Same author

C-reactive Protein in TB Meningitis: Signal, Surrogate, or Saboteur?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Restoring TB-specific Immunity in Early HIV Infection-the Dual Promise of Early Antiretroviral and TB Preventive Treatment.

The Journal of infectious diseases·2025
Same author

Investigating Indicators to Assess and Support Alcohol Taxation Policy: Results From the International Alcohol Control (IAC) Study.

International journal of health policy and management·2025
Same author

Long-term Protection From Tuberculosis Preventive Treatment Among People With HIV in a High-Burden Tuberculosis Setting: An Observational Cohort Study From India.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Related Experiment Video

Updated: Apr 8, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K

Evaluating Tuberculosis Surveillance Using Global Standards and Benchmarks in the Philippines: Mixed Methods Study.

Minal Ahson1,2, Donna Mae Gaviola3, Stephanie O'Connor1

  • 1Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA, 30333, United States, 1 4044018024.

JMIR Public Health and Surveillance
|April 6, 2026
PubMed
Summary
This summary is machine-generated.

The Philippines

Keywords:
Philippinescase notificationdata qualitydisease surveillanceelectronic health recordshealth information systemspublic health surveillancesurveillancesurveillance evaluationtuberculosistuberculosis surveillance

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K
Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

642

Related Experiment Videos

Last Updated: Apr 8, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

15.0K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K
Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

642

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Surveillance

Background:

  • The Philippines faces a significant global tuberculosis (TB) burden, with 741,000 estimated cases and 40,000 deaths in 2022.
  • An estimated 350,000 new TB diagnoses go unreported annually in the country.
  • Addressing the TB epidemic requires robust and accurate national surveillance systems.

Purpose of the Study:

  • To assess the accuracy, completeness, and timeliness of the national TB surveillance system in the Philippines.
  • To evaluate the system against global TB surveillance standards and benchmarks.
  • To identify areas for improvement in TB case reporting and management.

Main Methods:

  • A mixed-methods approach involving field visits to 9 purposively selected health facilities across 4 regions.
  • Review of health records and interviews with key informants to evaluate TB surveillance activities.
  • Assessment against 16 globally accepted TB surveillance performance standards.

Main Results:

  • Only 25% of performance standards were fully met, with 56.3% partially met and 18.8% not met, an improvement since 2019.
  • Significant local variations exist in electronic reporting adoption and quality assurance practices.
  • Over 50% of reported TB cases lacked bacteriological confirmation, and underreporting/underdiagnosis was prevalent.
  • Delayed reporting was common, particularly in areas with limited connectivity or medication access.

Conclusions:

  • Data quality assurance, case verification gaps, and reporting timeliness pose threats to surveillance integrity.
  • Enhanced monitoring, evaluation, and targeted studies (e.g., national TB inventory) are crucial.
  • These interventions can quantify underreporting, guide funding, and track progress toward TB elimination targets.